North Star Investment Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$140K	Hold	3,900	–	–	0.01%	474
2025 Q1	$154K	Hold	3,900	–	–	0.01%	448
2024 Q4	$117K	Sell	3,900 -10,000	-72%	-$301K	0.01%	484
2024 Q3	$325K	Sell	13,900 -5,000	-26%	-$117K	0.02%	366
2024 Q2	$336K	Hold	18,900	–	–	0.02%	367
2024 Q1	$287K	Sell	18,900 -11,500	-38%	-$175K	0.02%	381
2023 Q4	$519K	Buy	30,400 +26,000	+591%	+$444K	0.04%	324
2023 Q3	$36.8K	Hold	4,400	–	–	﹤0.01%	645
2023 Q2	$109K	Hold	4,400	–	–	0.01%	503
2023 Q1	$66.2K	Hold	4,400	–	–	0.01%	582
2022 Q4	$52.1K	Hold	4,400	–	–	﹤0.01%	588
2022 Q3	$26K	Hold	4,400	–	–	﹤0.01%	652
2022 Q2	$19K	Sell	4,400 -25,000	-85%	-$108K	﹤0.01%	721
2022 Q1	$280K	Buy	29,400 +26,000	+765%	+$248K	0.02%	352
2021 Q4	$65K	Hold	3,400	–	–	﹤0.01%	560
2021 Q3	$113K	Buy	+3,400	New	+$113K	0.01%	456
2020 Q2	–	Sell	-21,000	Closed	-$207K	–	1035
2020 Q1	$207K	Hold	21,000	–	–	0.03%	314
2019 Q4	$233K	Hold	21,000	–	–	0.02%	347
2019 Q3	$118K	Hold	21,000	–	–	0.01%	410
2019 Q2	$182K	Hold	21,000	–	–	0.02%	366
2019 Q1	$169K	Hold	21,000	–	–	0.02%	374
2018 Q4	$86K	Hold	21,000	–	–	0.01%	437
2018 Q3	$118K	Hold	21,000	–	–	0.01%	421
2018 Q2	$276K	Hold	21,000	–	–	0.03%	323
2018 Q1	$298K	Hold	21,000	–	–	0.04%	314
2017 Q4	$172K	Hold	21,000	–	–	0.02%	362
2017 Q3	$249K	Hold	21,000	–	–	0.03%	321
2017 Q2	$211K	Hold	21,000	–	–	0.03%	342
2017 Q1	$245K	Buy	21,000 +11,000	+110%	+$128K	0.03%	317
2016 Q4	$46K	Buy	+10,000	New	+$46K	0.01%	509